Sign in
Skills³ coordination office
Interface Entreprises-Université
LIEGE science park
Avenue Pré-Aily, 4 (B60)
B- 4031 Angleur
Interface Entreprises-Université
LIEGE science park
Avenue Pré-Aily, 4 (B60)
B- 4031 Angleur
KitoZyme sa
Print this company profile
PI Hauts Sarts Z2 - Rue Haute Claire 4
4040 Herstal
Belgium
T 0032-4-2598500
F 0032-4-2598409
E info@kitozyme.com
W http://www.kitozyme.com
GERARD Marie
m.gerard@kitozyme.com
Staff Specialties:
biochemistry, biopolymers, medical/pharma, nutraceutics, cosmetics, beverages industry, regulatory
Located in Herstal, near Liège in Belgium, the company was founded in 2000 to capitalize on the great potential offered by eight years of research in the field of vegetal biopolymer extraction.
Nine years of development and over €25 million of investment later, the KitoZyme team now comprises 56 individuals and produces innovative, environmentally, friendly fungal biopolymers manufactured nowhere else in the world.
Profit
Company
Company
26-50 employees
Activities:
- Drugs and therapeutics
- Medical devices and equipment
- Agro/Food/Environment
Print this company profile
Contact
KitoZyme saPI Hauts Sarts Z2 - Rue Haute Claire 4
4040 Herstal
Belgium
T 0032-4-2598500
F 0032-4-2598409
E info@kitozyme.com
W http://www.kitozyme.com
HR Info
HR contact:GERARD Marie
m.gerard@kitozyme.com
Staff Specialties:
biochemistry, biopolymers, medical/pharma, nutraceutics, cosmetics, beverages industry, regulatory
Company Description
Spin off of the University of Liège, KitoZyme develops, produces and markets innovative, high valueadded vegetal biopolymers which offer multiple health and beauty benefits. The biopolymers are targeted at four markets: the cosmetic, nutraceutical, medical/pharmaceutical market (for medical devices and drug delivery systems) and the beverage treatment market. Located in Herstal, near Liège in Belgium, the company was founded in 2000 to capitalize on the great potential offered by eight years of research in the field of vegetal biopolymer extraction.
Nine years of development and over €25 million of investment later, the KitoZyme team now comprises 56 individuals and produces innovative, environmentally, friendly fungal biopolymers manufactured nowhere else in the world.
